77-LH-28-1

From WikiMD's WELLNESSPEDIA

77-LH-28-1.svg

77-LH-28-1 is a synthetic compound that has been studied for its potential pharmacological properties. It is primarily known for its role as a selective agonist for the serotonin receptor subtype 5-HT7.

Chemical Properties[edit]

77-LH-28-1 is a chemical compound with a specific molecular structure that allows it to interact selectively with the 5-HT7 receptor. The exact chemical formula and molecular weight of 77-LH-28-1 are essential for understanding its pharmacokinetics and pharmacodynamics.

Pharmacology[edit]

Mechanism of Action[edit]

77-LH-28-1 functions as an agonist at the 5-HT7 receptor, a subtype of the serotonin receptor family. The activation of the 5-HT7 receptor by 77-LH-28-1 can influence various physiological processes, including circadian rhythm, mood regulation, and cognitive function.

Potential Therapeutic Uses[edit]

Research into 77-LH-28-1 has suggested potential applications in the treatment of neurological disorders and psychiatric conditions. Its role in modulating the serotonin system makes it a candidate for further investigation in the context of depression, anxiety, and schizophrenia.

Research and Development[edit]

Studies on 77-LH-28-1 are ongoing, with a focus on its efficacy, safety, and potential side effects. Preclinical trials have shown promising results, but more research is needed to fully understand its therapeutic potential and to develop it into a viable medication.

See Also[edit]

References[edit]


External Links[edit]

-


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.